Dembelé M - Search Results

1

High incidence of sputum smear negative tuberculosis during HAART in Burkina Faso.

Dembelé M, Saleri N, Migliori GB, Ouedraogo H, Carvalho AC, Ouedraogo M, Badoum G, Matteelli A. Dembelé M, et al. Eur Respir J. 2008 Dec;32(6):1668-9. doi: 10.1183/09031936.00106308. Eur Respir J. 2008. PMID: 19043017 Free article. No abstract available.

2

Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?

Badoum G, Saleri N, Dembélé MS, Ouedraogo M, Pinsi G, Boncoungou K, Bonkoungou V, Birba E, Miotto P, Migliori GB, Cirillo DM, Matteelli A. Badoum G, et al. Among authors: dembele ms. Eur Respir J. 2011 May;37(5):1283-5. doi: 10.1183/09031936.00144710. Eur Respir J. 2011. PMID: 21532018 Free article. No abstract available.

3

Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.

Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, Koala ST, Simporé J, Matteelli A. Dembélé M, et al. Int J Tuberc Lung Dis. 2010 Mar;14(3):318-23. Int J Tuberc Lung Dis. 2010. PMID: 20132623

4

Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.

Miotto P, Saleri N, Dembelé M, Ouedraogo M, Badoum G, Pinsi G, Migliori GB, Matteelli A, Cirillo DM. Miotto P, et al. Among authors: dembele m. BMC Infect Dis. 2009 Aug 28;9:142. doi: 10.1186/1471-2334-9-142. BMC Infect Dis. 2009. PMID: 19715569 Free PMC article.

5

Obstacles to the implementation of directly observed treatment in Ouagadougou, Burkina Faso.

Ouédraogo M, Kouanda S, Dembélé M, Ouédraogo SM, Badoum G, Ouédraogo G, Bambara M, Yaogho MG, Drabo YJ. Ouédraogo M, et al. Among authors: dembele m. Int J Tuberc Lung Dis. 2006 Feb;10(2):188-91. Int J Tuberc Lung Dis. 2006. PMID: 16499259

6

Treatment seeking behaviour of smear-positive tuberculosis patients diagnosed in Burkina Faso.

Ouédraogo M, Kouanda S, Boncoungou K, Dembélé M, Zoubga ZA, Ouédraogo SM, Coulibaly G. Ouédraogo M, et al. Among authors: dembele m. Int J Tuberc Lung Dis. 2006 Feb;10(2):184-7. Int J Tuberc Lung Dis. 2006. PMID: 16499258

7

Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis.

Matteelli A, Saleri N, Villani P, Bonkoungou V, Carvalho AC, Kouanda S, Sanou MJ, Simporé J, Monno L, Carosi G, Regazzi M, Dembele M. Matteelli A, et al. Among authors: dembele m. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):64-9. doi: 10.1097/qai.0b013e3181b0328f. J Acquir Immune Defic Syndr. 2009. PMID: 19731452

8

Decentralising tuberculosis case management in two districts of Burkina Faso.

Drabo KM, Dauby C, Coste T, Dembelé M, Hien C, Ouedraogo A, Macq J, Ouedraogo JB, Dujardin B. Drabo KM, et al. Among authors: dembele m. Int J Tuberc Lung Dis. 2006 Jan;10(1):93-8. Int J Tuberc Lung Dis. 2006. PMID: 16466044

9

Access and adhering to tuberculosis treatment: barriers faced by patients and communities in Burkina Faso.

Sanou A, Dembele M, Theobald S, Macq J. Sanou A, et al. Among authors: dembele m. Int J Tuberc Lung Dis. 2004 Dec;8(12):1479-83. Int J Tuberc Lung Dis. 2004. PMID: 15636495

10

An exploration of the concept of directly observed treatment (DOT) for tuberculosis patients: from a uniform to a customised approach.

Macq JC, Theobald S, Dick J, Dembele M. Macq JC, et al. Among authors: dembele m. Int J Tuberc Lung Dis. 2003 Feb;7(2):103-9. Int J Tuberc Lung Dis. 2003. PMID: 12588009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters